MicroRNA-17 impairs glucose metabolism in insulin-resistant skeletal muscle via repressing glucose transporter 4 expression. 2018

Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), Harbin Medical University, Harbin 150081, China.

Elimination of glucose transporter 4 (GLUT4) inevitably induces insulin resistance (IR), aggravating inflammation- and oxidative stress-related disorders. However, the underlying molecular mechanisms remain incompletely understood. In this study, we identified miR-17 as an important regulator of IR by targeting GLUT4. MiR-17 expression was found significantly elevated in skeletal tissues of rats with type 2 diabetes mellitus (T2DM), along with marked downregulation of GLUT4 protein level. Luciferase reporter gene assay demonstrated a direct interaction between miR-17 and the 3'untranslated region of GLUT4 mRNA. Correlation analyses (Spearman, Pearson, and Kendall) revealed that miR-17 level was negatively correlated with GLUT4 expression. Additionally, loss- and gain-of-function analyses showed that overexpression of miR-17 impaired glucose metabolism in L6 rat skeletal muscle cell line. In contrast, knockdown of endogenous miR-17 ameliorated glucose metabolism, accompanied by elevation of GLUT4 protein level. These findings unraveled a novel mechanism for IR that involves repression of GLUT4 by miR-17 and suggested miR-17 as a potential molecular target for the development of new therapeutic approaches for the treatment of T2DM.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
April 2020, Canadian journal of diabetes,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
June 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
March 2007, Chinese journal of integrative medicine,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
April 2006, Clinical and experimental pharmacology & physiology,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
March 1991, The American journal of physiology,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
January 1995, Physiological research,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
August 2007, Experimental & molecular medicine,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
September 2000, American journal of physiology. Endocrinology and metabolism,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
September 2008, BMC cell biology,
Dan Xiao, and Tong Zhou, and Yujie Fu, and Rui Wang, and Haiying Zhang, and Mingqi Li, and Yuan Lin, and Zhange Li, and Chaoqian Xu, and Baofeng Yang, and Ying Zhang, and Yong Zhang
January 2013, PloS one,
Copied contents to your clipboard!